Fulgent Genetics, Inc. (NASDAQ: FLGT), a technology-based company renowned for its established laboratory services and therapeutic development businesses, has announced that it will release its financial results for the second quarter of 2024 on Friday, August 2, 2024, before the market opens.
In addition to releasing the financial results, Fulgent Genetics’ management will host a conference call for the investment community at 8:30 AM Eastern Time (5:30 AM Pacific Time) the same day. This call will provide an opportunity for analysts, investors, and other interested parties to discuss the financial performance of the company and to ask questions.
Fulgent Genetics, based in El Monte, California, has positioned itself as a leader in the field of genetic testing and diagnostics, providing a broad range of services and products to meet the needs of its diverse clientele, including healthcare providers, academic researchers, and pharmaceutical companies.
The upcoming financial results announcement and conference call are anticipated with interest, as they will provide critical insights into the company’s performance over the past quarter and its strategic direction moving forward.
Comments